52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial

Authors :: Emilie Soularue
F. Ghiringhelli
Vincent Bourgeois
Romain Coriat
Julien Edeline
Emilie Barbier
Pierre Michel
Samy Louafi
Laetitia Dahan
Sylvain Manfredi
Eric Terrebonne
V. Ly Lebrun
J.M. Phelip
Yann Molin
Jérôme Desramé
Thierry Lecomte
David Malka
Hervé Perrier
F. Khemissa Akouz
Cindy Neuzillet
Source :: Annals of Oncology. 31:S260-S261
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Biliary tract cancer
business.industry
FOLFIRINOX
Internal medicine
Medicine
Hematology
First line chemotherapy
business

Tools